title: [Burning mouth syndrome].
abstract: Burning mouth syndrome (BMS) is characterized by burning sensations of the oral cavity in the absence of abnormalities of the oral mucosa. BMS predominantly affects middle-aged women. This condition has a multifactorial etiology. Multiple approaches to treatment have been described. This article examines BMS, its related factors, and treatment options.
authors: Dipartimento di Scienze Stomatologiche G. Messina, Sezione di Odontostomatologia, Università, Palermo. scardina@odonto.unipa.it
authors: Giuseppe Alessandro
authors: GA
authors: Scardina
authors: Teresa
authors: T
authors: Pisano
authors: Pietro
authors: P
authors: Messina
mesh_terms: D000367:Age Factors; D000368:Aged; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use; D002054:Burning Mouth Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D000077206:Gabapentin; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012737:Sex Factors; D008063:Thioctic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000588:Amines; D000700:Analgesics; D014151:Anti-Anxiety Agents; D000975:Antioxidants; D003509:Cyclohexanecarboxylic Acids; D014803:Vitamin B Complex; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D008063:Thioctic Acid